Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents August 28, 2023; Volume Issue supplement 1

PhysicianPharm_Oral

    • Cardiovascular - Basic Science
    • Cardiovascular - Clinical Science
    • Educational Exhibits - Correlative Imaging (including instrumentation, image fusion and data analysis)
    • General Clinical Specialties - Gastroenterology
    • General Clinical Specialties - Infectious and Inflammatory Disease/Hematology/Musculoskeletal
    • General Clinical Specialties - Non-oncology Endocrinology/Neuroendocrine
    • General Clinical Specialties - Outcomes/Comparative Effectiveness Research & Radiation Safety
    • General Clinical Specialties - Pediatrics
    • General Clinical Specialties - Pulmonary
    • General Clinical Specialties - Renal/Hypertension
    • Molecular Targeting Probes-Radioactive & Nonradioactive - Novel Radiochemistry & Chelation
    • Molecular Targeting Probes-Radioactive & Nonradioactive - Automation & Technology Development
    • Molecular Targeting Probes-Radioactive & Nonradioactive - Dosimetry & Image Analysis
    • Molecular Targeting Probes-Radioactive & Nonradioactive - Novel Multimodality & Nonradioactive Probes
    • Molecular Targeting Probes-Radioactive & Nonradioactive - Preclinical Probes for Neuroimaging
    • Molecular Targeting Probes-Radioactive & Nonradioactive - Preclinical Probes for Oncology
    • Molecular Targeting Probes-Radioactive & Nonradioactive - Probes for Cardiovascular, Endocrine and Other - Preclinical
    • Molecular Targeting Probes-Radioactive & Nonradioactive - Radiopharmacy & Clinical Production
    • Neurosciences - Basic and Translational Neurosciences
    • Neurosciences - Clinical Neurosciences (including neuro-oncology)
    • Oncology, Basic and Translational - Early Phase (Phase 0 or I) human studies
    • Oncology, Basic and Translational - In vitro and In vivo Oncology
    • Oncology, Basic and Translational - Technical Advances & Quantification (this would include image-guided diagnostics/therapy)
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Breast Cancer
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Endocrine/Neuroendocrine Cancers
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GI
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GU
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GYN
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Head and Neck
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Hematologic Malignancies
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Other Solid Tumors
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Sarcoma/Melanoma
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Thoracic (Lung/Pleura)
    • Physics, Instrumentation & Data Sciences - Data Analysis & Management
    • Physics, Instrumentation & Data Sciences - Data Sciences
    • Physics, Instrumentation & Data Sciences - Image Generation
    • Physics, Instrumentation & Data Sciences - Instrumentation

PhysicianPharm_Poster

    • Cardiovascular - Basic Science
    • Cardiovascular - Clinical Science
    • Educational Exhibits - Cardiovascular Sciences
    • Educational Exhibits - Correlative Imaging (including instrumentation, image fusion and data analysis)
    • Educational Exhibits - General Clinical Specialties
    • Educational Exhibits - Neurosciences
    • Educational Exhibits - Oncology
    • Educational Exhibits - Professional Development & Quality Improvement
    • Educational Exhibits - Radiopharmaceutical Sciences
    • General Clinical Specialties - Gastroenterology
    • General Clinical Specialties - Infectious and Inflammatory Disease/Hematology/Musculoskeletal
    • General Clinical Specialties - Non-oncology Endocrinology/Neuroendocrine
    • General Clinical Specialties - Outcomes/Comparative Effectiveness Research & Radiation Safety
    • General Clinical Specialties - Pediatrics
    • General Clinical Specialties - Renal/Hypertension
    • Molecular Targeting Probes-Radioactive & Nonradioactive - Novel Radiochemistry & Chelation
    • Molecular Targeting Probes-Radioactive & Nonradioactive - Automation & Technology Development
    • Molecular Targeting Probes-Radioactive & Nonradioactive - Dosimetry & Image Analysis
    • Molecular Targeting Probes-Radioactive & Nonradioactive - Infection and Inflammation in Probe Development
    • Molecular Targeting Probes-Radioactive & Nonradioactive - Novel Multimodality & Nonradioactive Probes
    • Molecular Targeting Probes-Radioactive & Nonradioactive - Preclinical Probes for Neuroimaging
    • Molecular Targeting Probes-Radioactive & Nonradioactive - Preclinical Probes for Oncology
    • Molecular Targeting Probes-Radioactive & Nonradioactive - Probes for Cardiovascular, Endocrine and Other - Preclinical
    • Molecular Targeting Probes-Radioactive & Nonradioactive - Radiopharmacy & Clinical Production
    • Neurosciences - Basic and Translational Neurosciences
    • Neurosciences - Clinical Neurosciences (including neuro-oncology)
    • Oncology, Basic and Translational - Early Phase (Phase 0 or I) human studies
    • Oncology, Basic and Translational - In vitro and In vivo Oncology
    • Oncology, Basic and Translational - Technical Advances & Quantification (this would include image-guided diagnostics/therapy)
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Breast Cancer
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Endocrine/Neuroendocrine Cancers
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GI
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GU
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GYN
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Head and Neck
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Hematologic Malignancies
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Other Solid Tumors
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Sarcoma/Melanoma
    • Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Thoracic (Lung/Pleura)
    • Physics, Instrumentation & Data Sciences - Data Analysis & Management
    • Physics, Instrumentation & Data Sciences - Data Sciences
    • Physics, Instrumentation & Data Sciences - Image Generation
    • Physics, Instrumentation & Data Sciences - Instrumentation

Student_Oral

    • Cardiology
    • General Nuclear Medicine
    • Instrumentation
    • PET
    • Radiation Safety & Patient Care
    • Radiopharmacy
    • Theranostics

Student_poster

    • General Nuclear Medicine
    • PET
    • Theranostics

Technologist_Oral

    • Clinical PET
    • Diagnostic & Therapeutic Nuclear Medicine
    • Instrumentation & Data Analysis
    • Professional Practices & Educational Exhibits

Technologist_Poster

    • Cardiovascular Sciences
    • Clinical PET
    • Diagnostic & Therapeutic Nuclear Medicine
    • Instrumentation & Data Analysis
    • Neurosciences
    • Pre-clinical Studies (in vitro & animal efforts)
    • Professional Practices & Educational Exhibits
    • Radiopharmaceutical Science, Biology & Dosimetry
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
August 28, 2023
  • Table of Contents
  • Index by author
Sign up for alerts

Jump to

  • PhysicianPharm_Oral
  • PhysicianPharm_Poster
  • Student_Oral
  • Student_poster
  • Technologist_Oral
  • Technologist_Poster
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire